Literature DB >> 34613858

Impact of local vaccine subsidization programs on the prevention of mumps in Japan.

Makoto Miyazaki1, Taku Obara2,3, Nariyasu Mano1,2.   

Abstract

In Japan, although a mumps vaccination is outside the national universal vaccination program, some local governments have implemented their own program. However, little is known regarding the implementation status and the impact of these programs. In this study, we investigated the impact on the prevention of mumps, after identification of the status of the local government subsidization programs. We identified the implementation status of the subsidization programs using the websites of local governments. We retrieved the number of reported mumps cases from designated sentinel sites through the Surveillance of Infectious Diseases System implemented according to the Infectious Disease Control Law. Using this data, the impact of the subsidization program on prevention of mumps was assessed by comparing the number of mumps cases per site during the 2015-2016 outbreak among the areas categorized by the subsidization status, using a Poisson regression model. As of 2019, 26.2% (456/1,739) of the local governments were considered as having subsidization programs. We retrieved 52,719 mumps cases from 2010 to 2019. The number of mumps cases per sentinel site tended to be low in areas implementing a subsidization program, compared with the no-implementation areas throughout the data collection period. The adjusted model confirmed that the subsidization program implemented between 2010 and 2015 impacted on the number of mumps cases during the 2015-2016 outbreak, with a decrease in the numbers. Further studies with detailed data including vaccination coverage should be conducted.

Entities:  

Keywords:  Japan; Local subsidization; impact of mumps vaccination; mumps vaccination; prevention

Mesh:

Substances:

Year:  2021        PMID: 34613858      PMCID: PMC8828109          DOI: 10.1080/21645515.2021.1974797

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  9 in total

Review 1.  Immunisation and herd immunity.

Authors:  R M Anderson; R M May
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

2.  The estimated impact of decreased childhood vaccination due to COVID-19 using a dynamic transmission model of mumps in Japan.

Authors:  Taito Kitano; Hirosato Aoki
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

3.  Close the gap for routine mumps vaccination in Japan.

Authors:  Taito Kitano
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

Review 4.  Herd immunity: history, theory, practice.

Authors:  P E Fine
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

5.  Trends in varicella and mumps vaccination rates in children under 3 years of age in a tertiary children's hospital in Japan.

Authors:  Yoshihiko Morikawa; Saeko Morino; Kenta Ito; Mihoko Furuichi; Shigeko Miyokawa; Takayo Shoji; Yuho Horikoshi
Journal:  Pediatr Int       Date:  2019-09       Impact factor: 1.524

Review 6.  Mumps.

Authors:  Anders Hviid; Steven Rubin; Kathrin Mühlemann
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

7.  Effects of a Public Subsidy Program for Mumps Vaccine on Reducing the Disease Burden in Nagoya City, Japan.

Authors:  Takao Ozaki; Yasuhiro Goto; Naoko Nishimura; Takashi Nakano; Hideaki Kumihashi; Munehide Kano; Satoko Ohfuji
Journal:  Jpn J Infect Dis       Date:  2018-10-31       Impact factor: 1.362

8.  Seroprevalence of anti-mumps virus IgG antibody titer and voluntary mumps vaccination coverage in young adults in Japan.

Authors:  Hiraku Sasaki; Tomoko Fukunaga; Ai Asano; Kansuke Yamanaka; Kota Oikawa; Nobuto Shibata
Journal:  Hum Vaccin Immunother       Date:  2021-04-20       Impact factor: 3.452

Review 9.  Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine.

Authors:  Shih-Bin Su; Hsiao-Liang Chang; And Kow-Tong Chen
Journal:  Int J Environ Res Public Health       Date:  2020-03-05       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.